Oregon Governor Tina Kotek (D) announced that the state has secured a new supply of the abortion drug mifepristone that will last almost the entirety of the second Trump administration.
in announcementKotek's office directly cited “national election results” for why the Oregon Health Authority (OHA) and Oregon Health & Science University (OHSU) renewed their agreement to provide emergency mifepristone. .
In 2023, Kotec ordered OHA to secure a three-year supply of mifepristone through a partnership with OSHU. That supply is scheduled to expire next September. The new supply expires in September 2028.
“I believe in reproductive freedom and am committed to passionately advocating for access to safe reproductive health services for all people, regardless of their country's circumstances,” Kotek said in a statement.
“Oregon is not immune from federal attacks on our reproductive rights. In our state, patients can continue to access the medicines they need and healthcare providers can continue to do so without fear or harassment. We provide these important services.”
President-elect Trump has vowed to leave abortion as a state issue and not issue a nationwide abortion ban, but there are questions about how his second term will affect access to reproductive health care. Anxiety is increasing.
Orders for the morning-after pill and abortion pills mifepristone and misoprostol surged in the wake of the 2024 presidential election results. And anti-abortion groups are already plotting ways to circumvent state laws governing abortion access, including going after abortion pills.
